Literature DB >> 7784102

Subanesthetic concentrations of lidocaine selectively inhibit a nociceptive response in the isolated rat spinal cord.

Richard A Jaffe1, Michael A Rowe.   

Abstract

Systemically administered local anesthetics are known to provide analgesia in a variety of pain states; however, the site of action and the mechanism by which these effects are produced remain in question. In the present study, the effects of low (subblocking for nerve conduction) concentrations of lidocaine on a spinal cord nociceptive potential were studied. Spinal cords were removed from neonatal rats and maintained in vitro. Lumbar dorsal and ipsilateral ventral roots were attached to suction electrodes for stimulation and recording, respectively. Following a stabilization period (60-120 min) with control measurements, each preparation was exposed to a single concentration of lidocaine (30-60 min) then returned to control perfusate for recovery (60-120 min). Data were digitized and integrals computed for both monosynaptic and slow ventral root potentials (VRP). Low concentrations of lidocaine produced a selective reduction in the magnitude of the slow-VRP. At lidocaine concentrations of 1-10 micrograms/ml (3.6-36 microM), the slow-VRP was reduced from 79% to 36% of control. Recovery to pre-exposure control levels was slow and sometimes not complete after 60-120 min in drug-free perfusate. The monosynaptic component of the VRP was unaffected by lidocaine at any concentration, suggesting that the depression of the slow-VRP cannot be attributed to simple conduction block. The addition of naloxone 0.1 microM to the perfusate had minimal effect on lidocaine-induced depression. Although resembling the selective effects of morphine, the antinociceptive effects of lidocaine do not appear to be primarily mediated through opiate receptors.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7784102     DOI: 10.1016/0304-3959(94)00117-W

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  7 in total

1.  Intravenous Lidocaine for Refractory Chronic Orofacial Pain: Two case reports and a literature review.

Authors:  Abdulaziz Almahrezi; Louise Lamb; Mark A Ware; Yoram Shir; Ibrahim Al-Zakwani
Journal:  Sultan Qaboos Univ Med J       Date:  2008-07

Review 2.  Patient-controlled analgesia in the management of postoperative pain.

Authors:  Mona Momeni; Manuela Crucitti; Marc De Kock
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 3.  Perioperative Use of Intravenous Lidocaine.

Authors:  Marc Beaussier; Alain Delbos; Axel Maurice-Szamburski; Claude Ecoffey; Luc Mercadal
Journal:  Drugs       Date:  2018-08       Impact factor: 9.546

4.  Effects of intravenous sodium amobarbital vs lidocaine on pain and sensory abnormalities in patients with spinal cord injury.

Authors:  Angela Mailis-Gagnon; Balaji Yegneswaran; Bob Bharatwal; Andrei V Krassioukov
Journal:  J Spinal Cord Med       Date:  2009       Impact factor: 1.985

5.  Analgesic and antineuropathic drugs acting through central cholinergic mechanisms.

Authors:  Alessandro Bartolini; Lorenzo Di Cesare Mannelli; Carla Ghelardini
Journal:  Recent Pat CNS Drug Discov       Date:  2011-05-01

Review 6.  Mechanisms of action of the erector spinae plane (ESP) block: a narrative review.

Authors:  Ki Jinn Chin; Kariem El-Boghdadly
Journal:  Can J Anaesth       Date:  2021-01-06       Impact factor: 6.713

7.  Intravenous administration of lidocaine directly acts on spinal dorsal horn and produces analgesic effect: An in vivo patch-clamp analysis.

Authors:  Miyuki Kurabe; Hidemasa Furue; Tatsuro Kohno
Journal:  Sci Rep       Date:  2016-05-18       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.